Comparison of the Effects of Sacral Erector Spinae Plane Block and Dorsal Penile Block on Postoperative Pain in Circumcision Procedures

Launched by KONYA CITY HOSPITAL · Feb 19, 2025

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of pain relief for children undergoing circumcision, which is a common surgical procedure. The trial aims to compare the effectiveness of a specific type of nerve block called the sacral erector spinae plane (ESP) block with another method known as the dorsal penile block. Both techniques are designed to help reduce pain after surgery, which can be significant and affect a child's recovery. The goal is to find out which method provides better pain relief, allowing children to recover more comfortably and quickly.

To participate in this trial, children must be between 7 and 12 years old and in good health (specifically, classified as ASA Physical Status 1 or 2, which means they have no serious health issues). They should be scheduled for a circumcision and expected to stay in the hospital for at least one day after the procedure. However, children with certain medical conditions or those who cannot have anesthesia safely will not be included. Families of eligible participants can expect that their child will receive either of the pain relief methods during the surgery, and the research team will monitor their recovery closely to gather important information about pain management in pediatric patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Inclusion criteria of the patients: Age between 7-12 years, ASA Physical Status 1 and 2, circumcision surgery, general anesthesia, planned hospital stay of at least 24 hours.
• Exclusion Criteria:
• • Exclusion criteria were defined as patients whose family or personal consent could not be obtained for the study, Asa 3 and above cases, patients in the study age group who will undergo emergency surgery, patients with serious hematopoietic system, cardiovascular, liver or kidney disease, patients receiving anticoagulation therapy, patients with sensitivity to regional anesthetic agents and patients who have previously undergone penile surgery.